DANIELLE HECK: Open Payments
NPI 1023480753 · THE COLONY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 75 payments from 24 companies in 2025. Trend: 2023 $1,180 · 2024 $1,303 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $213 |
| Novo Nordisk Inc | 11 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Lilly USA, LLC | 5 | $74 |
| Phathom Pharmaceuticals, Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Amgen Inc. | 4 | $59 |
| Seqirus USA Inc | 3 | $53 |
Products named: Kerendia, VRAYLAR, MOUNJARO, Wegovy, VOQUEZNA, Auvelity, AZMIRO, UBRELVY.
Industry payments across TX — which companies pay providers there.
